We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$656M
AUM Growth
+$43.2M
Cap. Flow
-$10.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
40
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.77M
2
CNC icon
Centene
CNC
+$5.07M
3
LCI
Lannett Company, Inc.
LCI
+$4.41M
4
VTRS icon
Viatris
VTRS
+$4.34M
5
CVS icon
CVS Health
CVS
+$4.04M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.6M
2
RDY icon
Dr. Reddy's Laboratories
RDY
+$8.31M
3
KITE
Kite Pharma, Inc.
KITE
+$7.43M
4
THC icon
Tenet Healthcare
THC
+$3.82M
5
ABT icon
Abbott
ABT
+$3.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COO icon
76
Cooper Companies
COO
$14.6B
$2.48M 0.38%
74,000
– –
RDUS
77
DELISTED
Radius Health, Inc.
RDUS
$2.46M 0.38%
+40,000
New +$2.53M
GMED icon
78
Globus Medical
GMED
$10.9B
$2.44M 0.37%
87,700
– –
TFX icon
79
Teleflex
TFX
$6.06B
$2.44M 0.37%
18,557
– –
NUVA
80
DELISTED
NuVasive, Inc.
NUVA
$2.44M 0.37%
45,000
– –
HCSG icon
81
Healthcare Services Group
HCSG
$1.57B
$2.27M 0.35%
65,000
– –
ALNY icon
82
Alnylam Pharmaceuticals
ALNY
$30.6B
$2.26M 0.34%
24,000
-8,000
-25% -$742K
ZLTQ
83
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.14M 0.33%
+75,000
New +$2.37M
PRTA icon
84
Prothena Corp
PRTA
$444M
$2.11M 0.32%
31,000
+16,000
+107% +$965K
ICPT
85
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.02M 0.31%
13,500
+4,800
+55% +$813K
BLUE
86
DELISTED
bluebird bio
BLUE
$1.86M 0.28%
2,239
+656
+41% +$655K
CLVS
87
DELISTED
Clovis Oncology, Inc.
CLVS
$1.84M 0.28%
52,500
-2,500
-5% -$161K
SRCL
88
DELISTED
Stericycle Inc
SRCL
$1.81M 0.28%
15,000
-5,000
-25% -$637K
PTCT icon
89
PTC Therapeutics
PTCT
$5.78B
$1.78M 0.27%
+55,000
New +$1.62M
INO icon
90
Inovio Pharmaceuticals
INO
$70M
$1.78M 0.27%
22,083
– –
WMGI
91
DELISTED
Wright Medical Group Inc
WMGI
$1.7M 0.26%
70,309
+60,309
+603% +$1.31M
JUNO
92
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.63M 0.25%
37,000
+4,000
+12% +$198K
ACAD icon
93
Acadia Pharmaceuticals
ACAD
$4.93B
$1.6M 0.24%
45,000
-14,000
-24% -$493K
WCG
94
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.56M 0.24%
20,000
– –
UTHR icon
95
United Therapeutics
UTHR
$22B
$1.46M 0.22%
9,300
– –
DVA icon
96
DaVita
DVA
$12.1B
$1.39M 0.21%
20,000
– –
INFI
97
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.26M 0.19%
160,000
+30,000
+23% +$258K
LH icon
98
Labcorp
LH
$25.4B
$1.24M 0.19%
11,640
– –
ANGO icon
99
AngioDynamics
ANGO
$622M
$1.21M 0.19%
100,000
– –
RARE icon
100
Ultragenyx Pharmaceutical
RARE
$2.46B
$1.12M 0.17%
+10,000
New +$1,000K
2 3
4
5 6

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.55% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q4 2015 Portfolio in Review

As of Q4 2015, Bellevue Asset Management (Switzerland) held 140 positions worth $656M, up 7% from $613M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q4 2015 filing shows 7 new, 40 increased, 26 reduced and 13 closed positions. Its largest new stake was Lannett Company, Inc.: 26,870 shares worth $4.31M. The largest sale was Allergan plc, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q4 2015 buy was Lannett Company, Inc.: 26,870 shares worth $4.31M.
  • Bellevue Asset Management (Switzerland) added most to Cardinal Health in Q4 2015, an estimated $7.77M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q4 2015 reduction was Kite Pharma, Inc., cutting an estimated $7.43M.
  • Bellevue Asset Management (Switzerland) fully exited Allergan plc in Q4 2015, selling an estimated $13.6M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 31% of its $656M portfolio in Q4 2015.
  • Bellevue Asset Management (Switzerland) opened 7 new positions and closed 13 in Q4 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 7% quarter-over-quarter to $656M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.